Study: Eltrombopag may effectively treat liver diseases, HCV

12/3/2007 | Google

Eltrombopag could help boost blood platelet counts in patients with hepatitis C and other liver diseases and could also be used to treat cancer and a common blood disorder, according to studies. The results showed 75% of hepatitis C patients who took the drug had significantly higher platelet counts.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR